Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer. Issue 4 (8th September 2017)

• Record Type: Journal Article
• Authors: Bahreyni, Amirhossein; Samani, Seyed S.; Ghorbani, Elnaz; Rahmani, Farzad; khayami, Reza; Toroghian, Younes; Behnam‐Rassouli, Reihane; Khazaei, Majid; Ryzhikov, Mikhail; Parizadeh, Mohammad R.; Hasanzadeh, Malihe; Avan, Amir; Hassanian, Seyed M.
• Is Part Of: Journal of cellular physiology. Volume 233:Issue 4(2018:Apr.)
• Page Start: 2715
• Page End: 2722
• Publication Date: 2017-09-08
• Subjects: adenosine -- adenosine signaling -- gynecological cancer; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.26056
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract : Extracellular concentration of adenosine increases in the hypoxic tumor microenvironment. Adenosine signaling regulates apoptosis, angiogenesis, metastasis, and immune suppression in cancer cells. Adenosine‐induced cell responses depend upon different subtypes of adenosine receptors activation and type of cancer. Suppression of adenosine signaling via inhibition of adenosine receptors or adenosine generating enzymes including CD39 and CD73 on ovarian or cervical cancer cells is a potentially novel therapeutic approach for gynecological cancer patients. This review summarizes the role of adenosine in the pathogenesis of gynecological cancer for a better understanding and hence a better management of this disease. Abstract : Suppression of adenosine signaling via inhibition of adenosine receptors or adenosine generating enzymes including CD39 and CD73 on ovarian or cervical cancer cells is a potentially novel therapeutic approach for gynecological cancer patients. This review summarizes the role of adenosine in the pathogenesis of gynecological cancer for a better understanding and hence a better management of this disease.